Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS

https://doi.org/10.20996/1819-6446-2013-9-1-56-61

Full Text:

Abstract

Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic and docosahexaenoic acids in patients with recurrent atrial fibrillation and ventricular arrhythmias had been proven. The positive effect of the ω-3 PUFA on the risk of sudden arrhythmic death and overall mortality in the patients after myocardial infarction and patients with chronic heart failure had been also proven.

About the Authors

A. O. Malygin
Central Clinical Hospital and Outpatient Clinic of the President of the Russian Federation
Russian Federation


V. L. Doshchitsin
Central Clinical Hospital and Outpatient Clinic of the President of the Russian Federation
Russian Federation


References

1. АСС/АНА/ESC 2006 Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2006; 27: 2099–2140.

2. Lukomsky P. E., Bobkova B. I., Savenkov P. M. The Administration of Unsaturated Fatty Acids in Patients with Coronary Atherosclerosis. Cor et Vasa 1959; 1: 100.

3. Dyeberg J., Bang H.O., Stoffersen E. et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117–119.

4. Phillipson В. E., Rothrock D. W., Connor W. E. Reduction of plasma lipids, lipoproteins, and appoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210–1216.

5. Goodnight S.H. The antithrombotic effects of fish oil. In: Simopoulos A.P., Kifer R.R., Martin R.T., eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando, Fla: Academic Press; 1986; 135– 149.

6. Turner J., McLennan P. L., Abeywardena M. Y. Absence of coronary aortic atherosclerosis in rats having dietary lipid modified vulnerability to cardiac arrhythmias. Atherosclerosis 1990; 82:105–112.

7. Bang H. O., Dyerberg J., Hjorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200:69–73.

8. Hirai A., Terano T., Saito H. Clinical and epidemiological studies of eicosapentaenoic acid in Japan. In: Lands W.E.M., ed. Proceedings of the AOCS short course on polyunsaturated fatty acids and eicosanoids. Champaign, IL: American Oil Chemists' Society; 1987; 9–24.

9. Kromhout D., Bosschieter E.B., Coulander C. The inverse relation between fish consumption and 20year mortality from coronary heart disease. N Engl J Med 1985; 312; 1205–09.

10. Leaf A., Jorgensen M. B., Jacobs A. K. Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994; 90:2248–2257.

11. Coker S. J., Parratt J. R., Ledingham I. M. Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium. J Mol Cell Cardiol 1982; 14:483–5.

12. Coker S.J., Parratt J.R. AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion induced arrhythmias in anaesthetized greyhounds. Br J Pharmacol 1985; 86:259–264.

13. Chamock J.S., McLennan P.L., Abeywardena M.Y. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 1992; 116:19–25.

14. Charnock J. S. Lipids and cardiac arrhythmias. Prog Lipid Res 1994; 33:355–85.

15. Spector A. A., Yorek M. A. Membrane lipid composition and cellular function. J Lipid Res 1985; 26:1015– 35.

16. Charnock J. S., Abeywardena M. Y., McLennan P. L. Diet and cardiacarrhythmia: Effects of lipids on age related changes in myocardial function in the rat. Ann Nutr Metab 1985; 29:306.

17. Hallaq H., Smith T. W., Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U.S.A. 1992; 89:1760–4.

18. McLennan P. L. Relative effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 1993; 57:207–12.

19. McLennan P. L., Abeywardena M. Y., Charnock J. S. Reversal of arrhythmogenic effects of long term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am J Clin Nutr 1990; 51:53–58.

20. Kurien V. A., Oliver M. F. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet 1970; 1(7651): 813–815.

21. Van derVusse G. J., Glatz J.F.C., Stam H.C.G. Fatty acid homeostasis in the ormoxicand ischemic heart. Physiol Rev 1992; 72:881–940.

22. Oliver M. F., Opie L. H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994; 343:155–158.

23. Manning A. S., Hearse D. J. Reperfusion induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984; 16:497–518.

24. Billman G. E., Leaf A. The effects of omega-3 fatty acids on ventricular fibrillation induced by myocardial ischemia. In: Pownall, H. J. and Spector, A. A. eds. Omega-3 Fatty Acids in Nutrition, Vascular Biology and Medicine. Houston, TX: American Heart Association; 1994: 159–165.

25. Opie L. H. The Heart. Physiology and Metabolism. New York: Raven Press; 1991.

26. Weber P. C. Fish oil fatty acids and cardiovascular function: Epidemiology and biochemical mechanisms. Biochem Soc Trans 1990; 18:1045–1049.

27. Kinsella J. E., Lokesh B., Stone R. A. Dietary polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990; 52:1–28.

28. Hallaq H., Sellmayer A., Smith, T. W., Leaf A. Protective effects of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1990; 87:7834–7838.

29. Boland L., Drzewiecki M. Polyunsaturated fatty acid modulation of voltagegated ion channels. Cell Biohem Biophys 2008; 52: 59–84.

30. Kinoshita I., Itoh K., Nishida-Nakai M. Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarctionenhanced cardiac micro-somal (Ca2/-Mg2/)-ATPase activity. Jap J Circ 1994; 58:903–912.

31. Knapp H. R. Physiological and biochemical effects of fatty acids in man. In: Sinclair A., Gibson R. eds. Essential Fatty Acids and Eicosanoids. Champaign, IL: AOCS Publications; 1993: 330–333.

32. Dai J., Williams S. A., Ziegelhoffer A. Structure-activity relationship of the effect of cis-unsaturated fatty acids and heart sarcolemmal phospholipase D activity. Prostaglandins. Leukotrienes. Essent Fatty Acids 1995; 52:167–171.

33. Abeywardena M. Y., McLennan P. L., Charnock J. S. Role of eicosanoids in dietary fat modification of cardiac arrhythmia and ventricular fibrillation. In: Sinclair A., Gibson R. eds. Essential Fatty Acids and Eicosanoids. Champaign, IL: AOCS Publications; 1993: 257–261.

34. Pepe S., McLennan P. L. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr 1996; 126:34–42.

35. McLennan P. L., Abeywardena M. Y., Charnock J. S. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 1988; 116:709–717.

36. McLennan P.L., Bridle T.M., Abey wardena M.Y., Charnok J.S., Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 1992;123(6):1555–61.

37. McLennan P L., Abeywardena M. Y., Charnock J. S. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation. Can J Physiol Pharmacol 1985; 63:1411–1417.

38. McLennan P. L., Dallimore J. A. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr 1995; 125:1003–1009.

39. McLennan P., Howe P., Abeywardena M. Y., et al. The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 1996; 300:83–89.

40. Pepe S., McLennan P. L. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr 1996; 126:34–42.

41. Kang J. X., Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sc USA 1994; 91:9886–9890.

42. Leaf A. Omega-3 fatty acids and prevention of ventricular fibrillation. Prostaglandins. Leukotrienes. Essent Fatty Acids 1995; 52:197–198.

43. Bang H. O., et al. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr 1980; 33: 2657–2666.

44. Keys A. Seven countries. A multivariate analysis of diet and coronary heart disease. Cambridge, MA: Harvard University Press; 1980.

45. Kromhout D.t Bosschieter E. B., Coulander C. The inverse relation between fish consumption and 20year mortality from coronary heart disease. N Engl J Med 1985; 312:1205–1209.

46. Shekelle R. В., Missel, L., Paul O. Fish consumption and mortality from coronary heart disease. Lancet 1985; 313:820.

47. Burr M.L. Reflections on the diet and reinfarction trial (DART) Eur Heart J 2001; 3 (Suppl D): D75–78.

48. GISSI-Prevenzione Investigators Dietary supplementationwith n-3 polyunsaturated fatty acids and vitamin E aftermyocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354 (9177): 447–455.

49. GISSI-HF investigators. Effect of n-3 PUFA in patients with chronic heart failure: a randomized, doubleblind, pacebo-controlled trial. Lancet 2008; 372:1223–1130.

50. Carlo L., Bianconi L. Fatty acids for the prevention of atrial fibrillation after coronary bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45:1723–1728.

51. Panov A.V., Tatarskiy B.A., Gordeev M.L., et al. Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after surgical myocardial revascularization. Rational Pharmacother. Card. 2008; (3):

52. –30. Russian (Панов А.В, Татарский Б.А., Гордеев М.Л., и др. Омега-3-ПНЖК в профилактике фибрилляции предсердий после хирургической реваскуляризации миокарда. Рациональная Фармакотерапия в Кардиологии 2008; (3): 26–30).

53. Nodari S., Manerba A., Madureri A., et al. Effects of polyunsaturated fatty acids n-3 in the prophylaxis of atrial fibrillation relapses after external electric cardioversion. Eur. Heart J., 2006; 27, 887.

54. Antonchenko I.V., Tatarskiy B.A., Rodionov B.A., et al. The use of omega-3 polyunsaturated fatty acids in the treatment of paroxysmal atrial fibrillation. Vestnik Aritmologii 2009; 53: 5–11. Russian (Антонченко И.В., Татарский Б.А., Родионов B.А., и др. Использование омега-3 полиненасыщенных жирных кислот при лечении пароксизмальных форм фибрилляции предсердий. Вестник Аритмологии 2009; 53: 5–11).

55. Nifontov E.M., Shikhaliev D.R., Bogachev M.I., et al. Antiarrhythmic activity of omega-3 polyunsaturated fatty acids in patients with stable ischemic heart disease and ventricular rhythm disturbances. Kardiologiia 2010;50(12):4–9. Russian (Нифонтов Е. М., Шихалиев Д.Р., Красичков А.С., и др. Антиаритмическая эффективность омега-3 полиненасыщенных жирных кислот у больных стабильной ишемической болезнью сердца с желудочковыми нарушениями ритма. Кардиология 2010; 50(12): 4–9).


For citation:


Malygin A.O., Doshchitsin V.L. THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS. Rational Pharmacotherapy in Cardiology. 2013;9(1):56-61. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-1-56-61

Views: 464


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)